Cargando…
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
Malignant pleural effusion (MPE) is a common clinical problem in non-small cell lung carcinoma (NSCLC) patients; however, the underlying mechanisms are still largely unknown. Recent studies indicate that the frequency of the L858R mutant form of the epidermal growth factor receptor (EGFR-L858R) is h...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559673/ https://www.ncbi.nlm.nih.gov/pubmed/26338423 http://dx.doi.org/10.1038/srep13574 |
_version_ | 1782388816851501056 |
---|---|
author | Tsai, Meng-Feng Chang, Tzu-Hua Wu, Shang-Gin Yang, Hsiao-Yin Hsu, Yi-Chiung Yang, Pan-Chyr Shih, Jin-Yuan |
author_facet | Tsai, Meng-Feng Chang, Tzu-Hua Wu, Shang-Gin Yang, Hsiao-Yin Hsu, Yi-Chiung Yang, Pan-Chyr Shih, Jin-Yuan |
author_sort | Tsai, Meng-Feng |
collection | PubMed |
description | Malignant pleural effusion (MPE) is a common clinical problem in non-small cell lung carcinoma (NSCLC) patients; however, the underlying mechanisms are still largely unknown. Recent studies indicate that the frequency of the L858R mutant form of the epidermal growth factor receptor (EGFR-L858R) is higher in lung adenocarcinoma with MPE than in surgically resected specimens, suggesting that lung adenocarcinoma cells harboring this mutation tend to invade the adjacent pleural cavity. The purpose of this study was to clarify the relationship between the EGFR-L858R mutation and cancer cell invasion ability and to investigate the molecular mechanisms involved in the formation of MPE. We found that expression of EGFR-L858R in lung cancer cells resulted in up-regulation of the CXCR4 in association with increased cancer cell invasive ability and MPE formation. Ectopic expression of EGFR-L858R in lung cancer cells acted through activation of ERK signaling pathways to induce the expression of CXCR4. We also indicated that Inhibition of CXCR4 with small interfering RNA, neutralizing antibody, or receptor antagonist significantly suppressed the EGFR-L858R–dependent cell invasion. These results suggest that targeting the production of CXCR4 and blocking the CXCL12-CXCR4 pathway might be effective strategies for treating NSCLCs harboring a specific type of EGFR mutation. |
format | Online Article Text |
id | pubmed-4559673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-45596732015-09-11 EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway Tsai, Meng-Feng Chang, Tzu-Hua Wu, Shang-Gin Yang, Hsiao-Yin Hsu, Yi-Chiung Yang, Pan-Chyr Shih, Jin-Yuan Sci Rep Article Malignant pleural effusion (MPE) is a common clinical problem in non-small cell lung carcinoma (NSCLC) patients; however, the underlying mechanisms are still largely unknown. Recent studies indicate that the frequency of the L858R mutant form of the epidermal growth factor receptor (EGFR-L858R) is higher in lung adenocarcinoma with MPE than in surgically resected specimens, suggesting that lung adenocarcinoma cells harboring this mutation tend to invade the adjacent pleural cavity. The purpose of this study was to clarify the relationship between the EGFR-L858R mutation and cancer cell invasion ability and to investigate the molecular mechanisms involved in the formation of MPE. We found that expression of EGFR-L858R in lung cancer cells resulted in up-regulation of the CXCR4 in association with increased cancer cell invasive ability and MPE formation. Ectopic expression of EGFR-L858R in lung cancer cells acted through activation of ERK signaling pathways to induce the expression of CXCR4. We also indicated that Inhibition of CXCR4 with small interfering RNA, neutralizing antibody, or receptor antagonist significantly suppressed the EGFR-L858R–dependent cell invasion. These results suggest that targeting the production of CXCR4 and blocking the CXCL12-CXCR4 pathway might be effective strategies for treating NSCLCs harboring a specific type of EGFR mutation. Nature Publishing Group 2015-09-04 /pmc/articles/PMC4559673/ /pubmed/26338423 http://dx.doi.org/10.1038/srep13574 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Tsai, Meng-Feng Chang, Tzu-Hua Wu, Shang-Gin Yang, Hsiao-Yin Hsu, Yi-Chiung Yang, Pan-Chyr Shih, Jin-Yuan EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway |
title | EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway |
title_full | EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway |
title_fullStr | EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway |
title_full_unstemmed | EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway |
title_short | EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway |
title_sort | egfr-l858r mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the cxcl12-cxcr4 pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559673/ https://www.ncbi.nlm.nih.gov/pubmed/26338423 http://dx.doi.org/10.1038/srep13574 |
work_keys_str_mv | AT tsaimengfeng egfrl858rmutantenhanceslungadenocarcinomacellinvasiveabilityandpromotesmalignantpleuraleffusionformationthroughactivationofthecxcl12cxcr4pathway AT changtzuhua egfrl858rmutantenhanceslungadenocarcinomacellinvasiveabilityandpromotesmalignantpleuraleffusionformationthroughactivationofthecxcl12cxcr4pathway AT wushanggin egfrl858rmutantenhanceslungadenocarcinomacellinvasiveabilityandpromotesmalignantpleuraleffusionformationthroughactivationofthecxcl12cxcr4pathway AT yanghsiaoyin egfrl858rmutantenhanceslungadenocarcinomacellinvasiveabilityandpromotesmalignantpleuraleffusionformationthroughactivationofthecxcl12cxcr4pathway AT hsuyichiung egfrl858rmutantenhanceslungadenocarcinomacellinvasiveabilityandpromotesmalignantpleuraleffusionformationthroughactivationofthecxcl12cxcr4pathway AT yangpanchyr egfrl858rmutantenhanceslungadenocarcinomacellinvasiveabilityandpromotesmalignantpleuraleffusionformationthroughactivationofthecxcl12cxcr4pathway AT shihjinyuan egfrl858rmutantenhanceslungadenocarcinomacellinvasiveabilityandpromotesmalignantpleuraleffusionformationthroughactivationofthecxcl12cxcr4pathway |